XTX Topco’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.1K Buy
+12,627
New +$131K ﹤0.01% 3105
2025
Q3
Sell
-3,044
Closed -$24.4K 3087
2025
Q2
$24.4K Buy
3,044
+774
+34% +$5.66K ﹤0.01% 2137
2025
Q1
$16K Buy
+2,270
New +$24.5K ﹤0.01% 2183
2024
Q4
Sell
-1,480
Closed -$20.7K 2768
2024
Q3
$20.7K Buy
1,480
+628
+74% +$10K ﹤0.01% 1837
2024
Q2
$13.5K Sell
852
-1,296
-60% -$31.7K ﹤0.01% 1661
2024
Q1
$58K Buy
2,148
+727
+51% +$17.5K 0.01% 1450
2023
Q4
$28.7K Buy
1,421
+350
+33% +$4.83K 0.01% 1317
2023
Q3
$14.1K Buy
+1,071
New +$17.6K ﹤0.01% 1403
2022
Q3
Sell
-1,206
Closed -$57K 1311
2022
Q2
$57K Sell
1,206
-3,509
-74% -$164K 0.02% 734
2022
Q1
$292K Buy
+4,715
New +$389K 0.13% 277
2021
Q3
Sell
-621
Closed -$164K 967
2021
Q2
$164K Buy
+621
New +$192K 0.06% 590

Other funds holding PASG

XTX Topco's PASG Position: Q1 2026 in Review

XTX Topco opened a new position in Passage Bio (PASG) in Q1 2026: 12,627 shares worth $99.1K. The stake represents ﹤0.01% of the portfolio and ranks #3105 among its holdings. This is a return to the name: XTX Topco previously reported a position in PASG as recently as Q2 2025.

XTX Topco first reported a position in PASG in Q2 2021 and has held it in 11 quarters since. The position peaked at $292K in Q1 2022. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • XTX Topco held 12,627 shares of Passage Bio worth $99.1K as of Q1 2026.
  • Passage Bio was a new XTX Topco position in Q1 2026.
  • Passage Bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3105 holding.
  • XTX Topco first reported a position in Passage Bio in Q2 2021 and has held it in 11 quarters since.
  • XTX Topco's Passage Bio position peaked at $292K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.